QQ客服 官方微博 反馈留言

	R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma
	He, Xiao-Hui; Li, Bo; Yang, Sheng; Lu, Ning; Zhang, Xun; Zou, Shuang-Mei; Li, Ye-Xiong; Song, Yong-Wen; Zheng, Shan; Dong, Mei
	2012
卷号	31期号:6页码:306-314
关键词	Diffuse large B-cell lymphoma rituximab chemotherapy NF-kappa B immunohistochemistry
ISSN号	1000-467X
DOI	10.5732/cjc.011.10420
URL标识	查看原文
收录类别	SCIE ; PUBMED ; ISTIC ; CSCD
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6720922
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	He, Xiao-Hui,Li, Bo,Yang, Sheng,et al. R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma[J],2012,31(6):306-314.
APA	He, Xiao-Hui.,Li, Bo.,Yang, Sheng.,Lu, Ning.,Zhang, Xun.,...&Shi, Yuan-Kai.(2012).R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma.,31(6),306-314.
MLA	He, Xiao-Hui,et al."R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma".31.6(2012):306-314.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。